Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis
Gurdeep S. Sagoo(Newcastle University), Julian P. T. Higgins(University of Bristol), Iain Tatt, John Danesh(University of Cambridge), Ulf dé Fairé(Karolinska Institutet), Merel van Maarle, John J.P. Kastelein(QRx Pharma (United States)), Anna M. Bennet(University of Cambridge), Georgia Salanti(University of Bern), Adam S. Butterworth(University of Cambridge), Nadeem Sarwar(Bahria University), B. Wiman, J. Wouter Jukema(Leiden University Medical Center)
Cited by 132
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k